Minster Pharmaceuticals Overview

  • Founded
  • 2005
  • Status
  • Private
  • Employees
  • 10
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $6.94M
Latest Deal Amount

Minster Pharmaceuticals General Information


Developer of pharmaceutical compounds for the treatment of neurological and psychiatric disorders. The company operates in Tonabersat and Sabcomeline segments. The Tonabersat segment is for the prevention and treatment of migraine. The Sabcomeline segment is for the management of cognitive decline and negative symptoms in schizophrenia.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Audley End Business Centre
  • The Old Forge 56
  • Essex CB11 4JL
  • England, United Kingdom
+44 01799 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Minster Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 04-Jan-2010 $6.94M 000.00 00.000 Completed Generating Revenue
1. PIPE 02-Mar-2007 000.00 000.00 Completed Generating Revenue
To view Minster Pharmaceuticals’s complete valuation and funding history, request access »

Minster Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial